Biohaven Research Ltd.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Biohaven Research Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
/ 
Frequently asked questions
To buy Biohaven Research Ltd. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Biohaven Research Ltd. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Biohaven Research Ltd. is BHVN_NEW:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Biohaven Research Ltd. has its primary listing on New York Stock Exchange. You can trade Biohaven Research Ltd. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Biohaven Research Ltd. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Biohaven Research Ltd. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Biohaven Research Ltd..